Pretreatment with dexmedetomidine exerted neuroprotective effects in a model of cerebral ischemia-reperfusion by inhibiting the TLR4/NF-κB pathway and reducing inflammatory damage [36]. This evidence concerns the gene NFKB1 and brain ischemia.